Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study

Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study

Item
http://www.wikidata.org/entity/Q35178803
Sleep Optimization and Diabetes Control: A Review of the LiteratureCircadian Rhythm and Sleep Disruption: Causes, Metabolic Consequences, and CountermeasuresInteracting epidemics? Sleep curtailment, insulin resistance, and obesity.Genetic variation in MTNR1B is associated with gestational diabetes mellitus and contributes only to the absolute level of beta cell compensation in Mexican Americans.Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening.Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.The melatonin agonist ramelteon induces duration-dependent clock gene expression through cAMP signaling in pancreatic INS-1 β-cells.Melatonin improves sleep quality in hemodialysis patients.Characteristics and Trends in Hypnotics Consumption in the Largest Health Care System in Israel.The Effects of Ramelteon on Glucose Metabolism and Sleep Quality in Type 2 Diabetic Patients With Insomnia: A Pilot Prospective Randomized Controlled TrialThe relationship between sleep disturbance and glycaemic control in adults with type 2 diabetes: An integrative review.Prevalence, symptomatic features, and factors associated with sleep disturbance/insomnia in Japanese patients with type-2 diabetes.Melatonin: an adjunctive treatment for cardiometabolic disease?Poor Quality Control of Over-the-Counter Melatonin: What They Say Is Often Not What You GetA Pre-Exercise Dose of Melatonin Can Alter Substrate Use During Exercise.Association between insomnia and coping style in Japanese patients with type 2 diabetes mellitus.
P2860

Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study

Item
http://www.wikidata.org/entity/Q35178803
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Efficacy and safety of prolong ...... double-blind, crossover study
@ast
Efficacy and safety of prolong ...... double-blind, crossover study
@en
type
label
Efficacy and safety of prolong ...... double-blind, crossover study
@ast
Efficacy and safety of prolong ...... double-blind, crossover study
@en
prefLabel
Efficacy and safety of prolong ...... double-blind, crossover study
@ast
Efficacy and safety of prolong ...... double-blind, crossover study
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P50
P577
P698
P932
P356
P1433
P1476
Efficacy and safety of prolong ...... double-blind, crossover study
@en
P2093
P2860
P304
P31
P356
P478
P50
P577
P698
P932